The role of thrombomodulin lectin-like domain in inflammation

Journal of Biomedical Science

Volumn 19, Issue 1, 2012, Pages

  Li, Yi Heng ^a,b   Kuo, Cheng Hsiang ^b,c   Shi, Guey Yueh ^b,c   Wu, Hua Lin ^b,c  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Inflammation; Lectin; Thrombomodulin

Indexed keywords

CELL SURFACE PROTEIN; HEPARIN; LECTIN; PROTEIN C; RECOMBINANT PROTEIN; RECOMBINANT TMD1; RECOMBINANT TMD12; RECOMBINANT TMD123; THROMBIN; THROMBOMODULIN; UNCLASSIFIED DRUG; HIGH MOBILITY GROUP B1 PROTEIN; THBD PROTEIN, HUMAN;

ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; BLEEDING; CELL TYPE; DISSEMINATED INTRAVASCULAR CLOTTING; GLOMERULONEPHRITIS; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; INFLAMMATORY INFILTRATE; KIDNEY ISCHEMIA; KIDNEY TUBULE DAMAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; ARTHRITIS; BLOOD CLOTTING; CHEMICALLY INDUCED DISORDER; GENETICS; METABOLISM; PROTEIN TERTIARY STRUCTURE;

ARTHRITIS; BLOOD COAGULATION; GLOMERULONEPHRITIS; HMGB1 PROTEIN; HUMANS; INFLAMMATION; PROTEIN C; PROTEIN STRUCTURE, TERTIARY; SEPSIS; THROMBIN; THROMBOMODULIN;

EID: 84862791853     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-19-34     Document Type: Review

References (55)

1. Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene. Wen DZ, Dittman WA, Ye RD, Deaven LL, Majerus PW, Sadler JE, Biochemistry 1987 26 4350 4357 10.1021/bi00388a025 2822087 (Pubitemid 17137065)
2. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. Suzuki K, Kusumoto H, Deyashiki Y, Maruyama I, Zushi M, Kawahara S, Honda G, Yamamoto S, Horiguchi S, EMBO J 1987 6 1891 1897 2820710
3. The regulation of natural anticoagulant pathways. Esmon CT, Science 1987 235 1348 1352 10.1126/science.3029867 3029867 (Pubitemid 17041653)
4. The roles of protein C and thrombomodulin in the regulation of blood coagulation. Esmon CT, J Biol Chem 1989 264 4743 4746 2538457 (Pubitemid 19092874)
5. Thrombomodulin. Weiler H, Isermann B, J Thromb Haemost 2003 1 1515 1524 10.1046/j.1538-7836.2003.00306.x 12871287
6. Endothelium-specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile-onset thrombosis. Isermann B, Hendrickson SB, Zogg M, Wing M, Cummiskey M, Kisanuki YY, Yanagisawa M, Weiler H, J Clin Invest 2001 108 537 546 11518727 (Pubitemid 32777733)
7. Expression of thrombomodulin in atherosclerotic lesions and mitogenic activity of recombinant thrombomodulin in vascular smooth muscle cells. Tohda G, Oida K, Okada Y, Kosaka S, Okada E, Takahashi S, Ishii H, Miyamori I, Arterioscler Thromb Vasc Biol 1998 18 1861 1869 10.1161/01.ATV.18.12.1861 9848877 (Pubitemid 28565747)
8. Functionally active thrombomodulin is present in human platelets. Suzuki K, Nishioka J, Hayashi T, Kosaka Y, J Biochem 1988 104 628 632 2853710
9. Thrombomodulin expression by human blood monocytes and by human synovial tissue lining macrophages. McCachren SS, Diggs J, Weinberg JB, Dittman WA, Blood 1991 78 3128 3132 1660324
10. Thrombomodulin is upregulated in cardiomyocytes during cardiac hypertrophy and prevents the progression of contractile dysfunction. Li YH, Chung HC, Luo CY, Chao TH, Shyu KG, Shi GY, Wu HL, J Card Fail 2010 16 980 990 10.1016/j.cardfail.2010.06.415 21111988
11. Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity. Zhang Y, Weiler-Guettler H, Chen J, Wilhelm O, Deng Y, Qiu F, Nakagawa K, Klevesath M, Wilhelm S, Böhrer H, Nakagawa M, Graeff H, Martin E, Stern DM, Rosenberg RD, Ziegler R, Nawroth PP, J Clin Invest 1998 101 1301 1309 10.1172/JCI925 9525972 (Pubitemid 28166827)
12. Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain. Horowitz NA, Blevins EA, Miller WM, Perry AR, Talmage KE, Mullins ES, Flick MJ, Queiroz KC, Shi K, Spek CA, Conway EM, Monia BP, Weiler H, Degen JL, Palumbo JS, Blood 2011 118 2889 2895 10.1182/blood-2011-03-341222 21788337
13. Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. Van de Wouwer M, Collen D, Conway EM, Arterioscler Thromb Vasc Biol 2004 24 1374 1383 10.1161/01.ATV.0000134298.25489.92 15178554 (Pubitemid 39050428)
14. Microthrombomodulin. Residues 310-486 from the epidermal growth factor precursor homology domain of thrombomodulin will accelerate protein C activation. Stearns DJ, Kurosawa S, Esmon CT, J Biol Chem 1989 264 3352 3356 2536746 (Pubitemid 19063390)
15. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Feistritzer C, Riewald M, Blood 2005 105 3178 3184 10.1182/blood-2004-10-3985 15626732
16. Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1. Schuepbach RA, Feistritzer C, Fernández JA, Griffin JH, Riewald M, Thromb Haemost 2009 101 724 733 19350118
17. Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K, Am J Physiol 1997 272 197 L202 9124369
18. Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation. Hirose K, Okajima K, Taoka Y, Uchiba M, Tagami H, Nakano K, Utoh J, Okabe H, Kitamura N, Ann Surg 2000 232 272 280 10.1097/00000658-200008000-00018 10903607 (Pubitemid 30616729)
19. Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Rabiet MJ, Plantier JL, Rival Y, Genoux Y, Lampugnani MG, Dejana E, Arterioscler Thromb Vasc Biol 1996 16 488 496 10.1161/01.ATV.16.3.488 8630677 (Pubitemid 26084325)
20. Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Colotta F, Sciacca FL, Sironi M, Luini W, Rabiet MJ, Mantovani A, Am J Pathol 1994 144 975 985 8178946 (Pubitemid 24160638)
21. Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). Kaplanski G, Marin V, Fabrigoule M, Boulay V, Benoliel AM, Bongrand P, Kaplanski S, Farnarier C, Blood 1998 92 1259 1267 9694714 (Pubitemid 28369039)
22. Vascular and dendritic cell coagulation signaling in sepsis progression. Ruf W, Furlan-Freguia C, Niessen F, J Thromb Haemost 2009 7 118 121 19630782
23. Thrombomodulin domains attenuate atherosclerosis by inhibiting thrombin-induced endothelial cell activation. Wei HJ, Li YH, Shi GY, Liu SL, Chang PC, Kuo CH, Wu HL, Cardiovasc Res 2011 92 317 327 10.1093/cvr/cvr220 21840881
24. Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI). Leung LL, Myles T, Nishimura T, Song JJ, Robinson WH, Mol Immunol 2008 45 4080 4083 10.1016/j.molimm.2008.07.010 18706698
25. Molecular model for the C-type lectin domain of human thrombomodulin. Villoutreix B, Dahlback B, J Mol Model 1998 4 310 322 10.1007/s008940050088 (Pubitemid 128664731)
26. The shape of thrombomodulin and interactions with thrombin as determined by electron microscopy. Weisel JW, Nagaswami C, Young TA, Light DR, J Biol Chem 1996 271 31485 31490 10.1074/jbc.271.49.31485 8940162 (Pubitemid 26408605)
27. Myeloid C-type lectin receptors in pathogen recognition and host defense. Osorio F, e Sousa CR, Immunity 2011 34 651 664 10.1016/j.immuni.2011.05.001 21616435
28. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kB and mitogen-activated protein kinase pathways. Conway EM, Van de Wouwer M, Pollefeyt S, Jurk K, Van Aken H, De Vriese A, Weitz JI, Weiler H, Hellings PW, Schaeffer P, Herbert JM, Collen D, Theilmeier G, J Exp Med 2002 196 565 577 10.1084/jem.20020077 12208873 (Pubitemid 35024436)
29. Thrombomodulin-mediated cell adhesion: involvement of its lectin-like domain. Huang HC, Shi GY, Jiang SJ, Shi CS, Wu CM, Yang HY, Wu HL, J Biol Chem 2003 278 46750 46759 10.1074/jbc.M305216200 12951323 (Pubitemid 37452254)
30. The role of thrombomodulin in atherosclerosis: from bench to bedside. Li YH, Shi GY, Wu HL, Cardiovasc Hematol Agents Med Chem 2006 4 183 187 10.2174/187152506776369953 16611051
31. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Scaffidi P, Misteli T, Bianchi ME, Nature 2002 418 191 195 10.1038/nature00858 12110890 (Pubitemid 34773774)
32. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME, Rubartelli A, EMBO Rep 2002 3 995 1001 10.1093/embo-reports/kvf198 12231511 (Pubitemid 35256475)
33. Targeting high mobility group box 1 as a late-acting mediator of inflammation. Czura CJ, Tracey KJ, Crit Care Med 2003 31 46 S50 10.1097/00003246-200301001-00007 12544976
34. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. Abeyama K, Stern DM, Ito Y, Kawahara K, Yoshimoto Y, Tanaka M, Uchimura T, Ida N, Yamazaki Y, Yamada S, Yamamoto Y, Yamamoto H, Iino S, Taniguchi N, Maruyama I, J Clin Invest 2005 115 1267 1274 15841214 (Pubitemid 40629045)
35. Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes. Ito T, Kawahara K, Okamoto K, Yamada S, Yasuda M, Imaizumi H, Nawa Y, Meng X, Shrestha B, Hashiguchi T, Maruyama I, Arterioscler Thromb Vasc Biol 2008 28 1825 1830 10.1161/ATVBAHA.107.150631 18599803
36. Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. Shi CS, Shi GY, Hsiao SM, Kao YC, Kuo KL, Ma CY, Kuo CH, Chang BI, Chang CF, Lin CH, Wong CH, Wu HL, Blood 2008 112 3661 3670 10.1182/blood-2008-03-142760 18711002
37. Lipopolysaccharide signaling in endothelial cells. Dauphinee SM, Karsan A, Lab Invest 2006 86 9 22 10.1038/labinvest.3700366 16357866 (Pubitemid 43250964)
38. Characterization of murine monoclonal antibodies against Helicobacter pylori lipopolysaccharide specific for Lex and Ley blood group determinants. Altman E, Harrison BA, Hirama T, Chandan V, To R, MacKenzie R, Biochem Cell Biol 2005 83 589 596 10.1139/o05-052 16234847 (Pubitemid 41812836)
39. The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis. Van de Wouwer M, Plaisance S, De Vriese A, Waelkens E, Collen D, Persson J, Daha MR, Conway EM, J Thromb Haemost 2006 4 1813 1824 10.1111/j.1538-7836.2006.02033.x 16879225 (Pubitemid 44144810)
40. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G, Del-Favero J, Plaisance S, Claes B, Lambrechts D, Zoja C, Remuzzi G, Conway EM, N Engl J Med 2009 361 345 357 10.1056/NEJMoa0810739 19625716
41. Harmful molecular mechanisms in sepsis. Rittirsch D, Flierl MA, Ward PA, Nat Rev Immunol 2008 8 776 787 10.1038/nri2402 18802444
42. Disseminated intravascular coagulation. Levi M, ten Cate H, N Engl J Med 1999 341 586 592 10.1056/NEJM199908193410807 10451465 (Pubitemid 29384168)
43. Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia. Nagato M, Okamoto K, Abe Y, Higure A, Yamaguchi K, Crit Care Med 2009 37 2181 2186 10.1097/CCM. 0b013e3181a55184 19487933
44. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. Saito H, Maruyama I, Shimazak S, Yamamoto Y, Aikawa N, Ohno R, Hirayama A, Matsuda T, Asakura H, Nakashima M, Aoki N, J Thromb Haemost 2007 5 31 41 10.1111/j.1538-7836.2006.02267.x 17059423 (Pubitemid 44921064)
45. Effects of human soluble thrombomodulin on experimental glomerulonephritis. Ikeguchi H, Maruyama S, Morita Y, Fujita Y, Kato, Natori Y, Akatsu H, Campbell W, Okada N, Okada H, Yuzawa Y, Matsuo S, Kidney Int 2002 61 490 501 10.1046/j.1523-1755.2002.00160.x 11849389 (Pubitemid 34102589)
46. Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure. Ozaki T, Anas C, Maruyama S, Yamamoto T, Yasuda K, Morita Y, Ito Y, Gotoh M, Yuzawa Y, Matsuo S, Nephrol Dial Transplant 2008 23 110 119 17804460 (Pubitemid 351767375)
47. Soluble thrombomodulin protects ischemic kidneys. Sharfuddin AA, Sandoval RM, Berg DT, McDougal GE, Campos SB, Phillips CL, Jones BE, Gupta A, Grinnell BW, Molitoris BA, J Am Soc Nephrol 2009 20 524 534 10.1681/ASN.2008060593 19176699
48. Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis. Bollee G, Flamant M, Schordan S, Fligny C, Rumpel E, Milon M, Schordan E, Sabaa N, Vandermeersch S, Galaup A, Rodenas A, Casal I, Sunnarborg SW, Salant DJ, Kopp JB, Threadgill DW, Quaggin SE, Dussaule JC, Germain S, Mesnard L, Endlich K, Boucheix C, Belenfant X, Callard P, Endlich N, Tharaux PL, Nat Med 2011 17 1242 1250 10.1038/nm.2491 21946538
49. EGFR signaling in podocytes at the root of glomerular disease. Harris R, Nat Med 2011 17 1188 1189 10.1038/nm.2455 21988993
50. The recombinant Lectin-like domain of thrombomodulin inhibits angiogenesis through interaction with Lewis Y antigen. Kuo CH, Chen PK, Chang BI, Sung MC, Shi CS, Lee JS, Chang CF, Shi GY, Wu HL, Blood 2012 119 1302 1313 10.1182/blood-2011-08-376038 22101897
51. Urinary thrombomodulin in patients with rheumatoid arthritis: relationship to disease subset. Hanyu T, Arai K, Nakano M, Clin Rheumatol 1999 18 385 389 10.1007/s100670050123 10524552 (Pubitemid 29479766)
52. Biologically active thrombomodulin is synthesized by adherent synovial fluid cells and is elevated in synovial fluid of patients with rheumatoid arthritis. Conway EM, Nowakowski B, Blood 1993 81 726 733 7678998 (Pubitemid 23040865)
53. Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator. Halloran MM, Carley WW, Polverini PJ, Haskell CJ, Phan S, Anderson BJ, Woods JM, Campbell PL, Volin MV, Backer AE, Koch AE, J Immunol 2000 164 4868 4877 10779796 (Pubitemid 30238091)
54. Thrombomodulin and its role in inflammation. Conway EM, Semin Immunopathol 2012 34 107 125 10.1007/s00281-011-0282-8 21805323
55. TM hidden treasure: lectin-like domain. Wu KK, Blood 2012 119 1103 1104 10.1182/blood-2011-12-394544 22308281